Bulletin of Experimental Biology and Medicine 2007-10-01

Study of bipathic effect of phenazepam.

O I Epstein, T A Voronina, G M Molodavkin, M V Belopol'skaya, I A Kheyfets, J L Dugina, S A Sergeeva

Index: Bull. Exp. Biol. Med. 144 , 536-538, (2007)

Full Text: HTML

Abstract

Phenazepam in ultralow doses significantly potentiated anxiolytic and anticonvulsant effects of therapeutic doses of the same drug both after preliminary or simultaneous administration, which attests to bipathic action of phenazepam. The combination of ultralow and therapeutic doses of phenazepam prevented the development of its specific myorelaxant and sedative side effects.

Related Compounds

Related Articles:

[Distribution of 14C-phenazepam and its metabolites in the liver, brain and blood plasma in single and prolonged administration to white rats].

1980-01-01

[Farmakol. Toksikol. 43(2) , 144-8, (1980)]

Phenazepam and its effects on driving.

2013-01-01

[J. Anal. Toxicol. 37(1) , 25-9, (2013)]

First reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confirmed recreational use of phenazepam.

2013-03-01

[Eur. J. Clin. Pharmacol. 69(3) , 361-3, (2013)]

Phenazepam: the drug that came in from the cold.

2012-04-01

[J. Forensic Leg. Med. 19(3) , 122-5, (2012)]

Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death.

2015-04-01

[Hum. Psychopharmacol. Clin. Exp. 27(3) , 254-61, (2012)]

More Articles...